A first-of-its-kind navigation acuity tool is entering a critical new phase of its development: an Institutional Review Board (IRB) quality initiative that will span 6 sites and include a minimum of 200 patients.
Every day in the United States, thousands of people are diagnosed with cancer, but very few are offered the opportunity to participate in a clinical trial, and only a small fraction of those come from underrepresented populations, according to Carmen E. Guerra, MD, MSCE, FACP, associate director of Diversity and Outreach at Abramson Cancer Center in Philadelphia.
The Commission on Cancer (CoC)—now 100 years old—is a consortium of professional organizations dedicated to improving survival and quality of life for patients with cancer through standard-setting, prevention, research, education, and the monitoring of comprehensive quality care, according to Frederick Greene, MD, FACS, a surgical oncologist at the Levine Cancer Institute in Charlotte, NC, and self-proclaimed “unabashed supporter of oncology nurse and patient navigators.
Navigators at the Miami Cancer Institute (MCI) have built a successful navigation program database to track patient care delivery and report metrics, according to Morgan Nestingen, MSN, APRN, AGCNS-BC, NEA-BC, OCN, ONN-CG, director of Nursing, Patient Intake and Navigation Services at MCI.
When it comes to cancer genetic testing and counseling, role delineation between oncology nurse navigators, patient navigators, and genetic counselors is vital to avoiding overlap of responsibilities and delivering quality patient care.
Research has shown that caregivers actually have higher depression and anxiety than patients with cancer, according to Vicki Mackie, founder and executive director of Sites and Insights, an international nonprofit dedicated to using color, art, and mindful healing programs to transform the lives of those impacted by cancer.
Results 1 - 6 of 6